Avid Bioservices Inc (CDMO)

[exwannabe]

OK, I will bite.

As best I know, the development path presently consists of:

A) Bavi - 2 single arm P2s in combo with chemo (not CIs or other immuno agents) and a trial to be named later.

. One in glio. a tough setting for IO agents where to date the cancer is pitching a perfect game. That blood brain thingee.

. A redo of the previous liver trial (that went nowhere) with some targeted radiation tossed in.

These will have data in 2021 or so that will highly likely not move the needle.

B) Exosomes. Ok, they are supposedly progressing, but non very open about it. At least I will credit that this path is clear.

C) Beta Bodies (for therapeutic use). Crickets